Marcela A. Hermoso

10.7k total citations · 4 hit papers
91 papers, 7.8k citations indexed

About

Marcela A. Hermoso is a scholar working on Molecular Biology, Immunology and Physiology. According to data from OpenAlex, Marcela A. Hermoso has authored 91 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 37 papers in Immunology and 27 papers in Physiology. Recurrent topics in Marcela A. Hermoso's work include Salivary Gland Disorders and Functions (23 papers), Inflammatory Bowel Disease (15 papers) and Gut microbiota and health (12 papers). Marcela A. Hermoso is often cited by papers focused on Salivary Gland Disorders and Functions (23 papers), Inflammatory Bowel Disease (15 papers) and Gut microbiota and health (12 papers). Marcela A. Hermoso collaborates with scholars based in Chile, United States and Netherlands. Marcela A. Hermoso's co-authors include Glauben Landskron, Marjorie De la Fuente, Rodrigo Quera, Marı́a Julieta González, Klaas Nico Faber, Gerard Dijkstra, Hermie J. M. Harmsen, Chanitra Thuwajit, Peti Thuwajit and Naschla Gasaly and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and PLoS ONE.

In The Last Decade

Marcela A. Hermoso

90 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases

2019 2.7k citations Glauben Landskron, Marı́a Julieta González et al. Frontiers in Immunology profile →
Chronic Inflammation and Cytokines in the Tumor Microenvironment

2014 1.4k citations Glauben Landskron, Marjorie De la Fuente et al. Journal of Immunology Research profile →
Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation

2021 354 citations Naschla Gasaly, Paul de Vos et al. Frontiers in Immunology profile →
Butyrate and the Fine-Tuning of Colonic Homeostasis: Implication for Inflammatory Bowel Diseases

2021 132 citations Naschla Gasaly, Marcela A. Hermoso et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marcela A. Hermoso Chile	34	3.9k	1.9k	1.5k	1.0k	1.0k	91	7.8k
Nagendra Singh United States	36	4.2k 1.1×	2.8k 1.5×	1.3k 0.8×	1.2k 1.2×	763 0.8×	86	8.3k
Mia Phillipson Sweden	40	3.3k 0.9×	2.5k 1.3×	1.2k 0.8×	571 0.6×	759 0.8×	96	8.4k
Carey Ann Gallini United States	13	5.6k 1.4×	1.5k 0.8×	1.3k 0.9×	1.2k 1.2×	999 1.0×	13	8.3k
Christian Jobin United States	48	5.1k 1.3×	2.7k 1.4×	914 0.6×	1.2k 1.2×	1.2k 1.2×	85	9.7k
Shanthi V. Sitaraman United States	52	4.1k 1.1×	1.8k 0.9×	1.2k 0.8×	847 0.8×	1.8k 1.8×	140	9.5k
Zhanju Liu China	45	4.1k 1.1×	2.6k 1.4×	934 0.6×	864 0.8×	2.0k 2.0×	172	8.3k
Y. Thomas United States	47	4.1k 1.1×	1.2k 0.6×	997 0.7×	675 0.7×	983 1.0×	94	8.6k
Marcello Chieppa Italy	39	2.2k 0.6×	3.3k 1.7×	1.1k 0.7×	918 0.9×	713 0.7×	91	7.2k
Koji Hase Japan	55	5.5k 1.4×	2.7k 1.4×	1.3k 0.9×	650 0.6×	853 0.9×	159	10.5k
Yun Kyung Lee South Korea	27	3.4k 0.9×	2.4k 1.2×	799 0.5×	951 0.9×	619 0.6×	59	7.1k

Countries citing papers authored by Marcela A. Hermoso

Since Specialization

Citations

This map shows the geographic impact of Marcela A. Hermoso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcela A. Hermoso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcela A. Hermoso more than expected).

Fields of papers citing papers by Marcela A. Hermoso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcela A. Hermoso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcela A. Hermoso. The network helps show where Marcela A. Hermoso may publish in the future.

Co-authorship network of co-authors of Marcela A. Hermoso

This figure shows the co-authorship network connecting the top 25 collaborators of Marcela A. Hermoso. A scholar is included among the top collaborators of Marcela A. Hermoso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcela A. Hermoso. Marcela A. Hermoso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Landskron, Glauben, Lorena Lobos‐González, Karen Dubois‐Camacho, et al.. (2024). Pannexin-1 expression in tumor cells correlates with colon cancer progression and survival. Life Sciences. 351. 122851–122851. 3 indexed citations

Linssen, Matthijs D., Michael Dobosz, Dominic J. Robinson, et al.. (2024). Fluorescently labelled vedolizumab to visualise drug distribution and mucosal target cells in inflammatory bowel disease. Gut. 73(9). 1454–1463. 7 indexed citations

Roozendaal, Caroline, et al.. (2024). DOP25 Antibodies against Neutrophil Extracellular Traps (ANETAs) are associated with more severe disease course in Ulcerative Colitis. Journal of Crohn s and Colitis. 18(Supplement_1). i119–i120. 1 indexed citations

Suárez, Felipe, et al.. (2023). Cyclooxygenase-2 Blockade Is Crucial to Restore Natural Killer Cell Activity before Anti-CTLA-4 Therapy against High-Grade Serous Ovarian Cancer. Cancers. 16(1). 80–80. 4 indexed citations

Fuente, Marjorie De la, Daniela Simian, Juan Aitken-Saavedra, et al.. (2023). Abstract 1251: Novel potential role of m6A-demethylase FTO (fat mass and obesity) protein in colorectal cancer. Cancer Research. 83(7_Supplement). 1251–1251. 1 indexed citations

Castro, Isabel, Patricia Carvajal, Daniela Jara, et al.. (2022). Small RNA Expression Profiling Reveals hsa-miR-181d-5p Downregulation Associated With TNF-α Overexpression in Sjögren’s Syndrome Patients. Frontiers in Immunology. 13. 870094–870094. 13 indexed citations

Gasaly, Naschla, Paul de Vos, & Marcela A. Hermoso. (2021). Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation. Frontiers in Immunology. 12. 354 indexed citations breakdown →

Barrera, María‐José, Sergio Aguilera, Isabel Castro, et al.. (2020). Tofacitinib counteracts IL-6 overexpression induced by deficient autophagy: implications in Sjögren’s syndrome. Lara D. Veeken. 60(4). 1951–1962. 36 indexed citations

Pérez, Federico, et al.. (2020). IL-33 Alarmin and Its Active Proinflammatory Fragments Are Released in Small Intestine in Celiac Disease. Frontiers in Immunology. 11. 581445–581445. 25 indexed citations

10.

Reyes, María Elena, Marjorie De la Fuente, Marcela A. Hermoso, Carmen Ili, & Priscilla Brebi. (2020). Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer. Frontiers in Immunology. 11. 901–901. 28 indexed citations

11.

Barrera, María‐José, Sergio Aguilera, Isabel Castro, et al.. (2018). Endoplasmic reticulum stress in autoimmune diseases: Can altered protein quality control and/or unfolded protein response contribute to autoimmunity? A critical review on Sjögren's syndrome. Autoimmunity Reviews. 17(8). 796–808. 34 indexed citations

12.

Dubois‐Camacho, Karen, David Díaz-Jiménez, Alejandro Torres, et al.. (2018). Glucocorticoids Impair Phagocytosis and Inflammatory Response Against Crohn’s Disease-Associated Adherent-Invasive Escherichia coli. Frontiers in Immunology. 9. 1026–1026. 27 indexed citations

13.

Díaz-Jiménez, David, Lucía Núñez, Marjorie De la Fuente, et al.. (2017). A functional IL1RL1 variant regulates corticosteroid-induced sST2 expression in ulcerative colitis. Scientific Reports. 7(1). 10180–10180. 9 indexed citations

14.

Díaz-Jiménez, David, Marjorie De la Fuente, Karen Dubois‐Camacho, et al.. (2016). Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution. BMC Gastroenterology. 16(1). 103–103. 31 indexed citations

15.

Landskron, Glauben, Marjorie De la Fuente, Peti Thuwajit, Chanitra Thuwajit, & Marcela A. Hermoso. (2014). Chronic Inflammation and Cytokines in the Tumor Microenvironment. Journal of Immunology Research. 2014. 1–19. 1379 indexed citations breakdown →

16.

Tittarelli, Andrés, Fermín E. González, Marcos Ramírez, et al.. (2011). Heat-Shock Induction of Tumor-Derived Danger Signals Mediates Rapid Monocyte Differentiation into Clinically Effective Dendritic Cells. Clinical Cancer Research. 17(8). 2474–2483. 70 indexed citations

17.

Beltrán, Caroll J., Enzo Candía, Benjamín Erranz, et al.. (2009). Peripheral cytokine profile in Chilean patients with Crohn’s disease and ulcerative colitis. European Cytokine Network. 20(1). 33–38. 10 indexed citations

18.

Beltrán, Caroll J., et al.. (2008). Enfermedad inflamatoria intestinal: Una mirada inmunológica. Revista médica de Chile. 136(3). 367–75. 12 indexed citations

19.

Arancibia, Sergio, et al.. (2007). Toll-like Receptors are Key Participants in Innate Immune Responses. Biological Research. 40(2). 97–112. 209 indexed citations

20.

Hermoso, Marcela A., Pablo Olivero, Rubén Torres, et al.. (2004). Cell Volume Regulation in Response to Hypotonicity Is Impaired in HeLa Cells Expressing a Protein Kinase C α Mutant Lacking Kinase Activity. Journal of Biological Chemistry. 279(17). 17681–17689. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact